Net Cash Provided by (Used in) Operating Activities |
-7.35K |
USD |
|
Q3 2022 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
10K |
USD |
|
Q3 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2023 |
FY 2023 |
Common Stock, Shares, Issued |
421K |
shares |
0% |
Q2 2023 |
FY 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
FY 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.65K |
USD |
|
Q3 2022 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
462K |
USD |
0% |
Q2 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
462K |
USD |
0% |
Q2 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.81M |
USD |
0% |
Q2 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
1K |
shares |
0% |
Q2 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2023 |
FY 2023 |
Additional Paid in Capital |
120M |
USD |
0% |
Q2 2023 |
FY 2023 |
Preferred Stock, Shares Outstanding |
1K |
shares |
0% |
Q2 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
FY 2023 |